| Name | 4-[4-(4-Hydroxy-3,5-dimethoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-2,6-dimethoxyphenyl hexopyranoside |
|---|---|
| Synonyms |
Hexopyranoside, 2,6-dimethoxy-4-[tetrahydro-4-(4-hydroxy-3,5-dimethoxyphenyl)-1H,3H-furo[3,4-c]furan-1-yl]phenyl
4-[4-(4-Hydroxy-3,5-dimethoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-2,6-dimethoxyphenyl hexopyranoside (-)-Syringaresinol 4-O-β-D-glucopyranoside |
| Description | Episyringaresinol 4'-O-β-D-glncopyranoside (compound 22), isolated from Alhagi sparsifolia Shap, is a natural potential neuroinflammatory inhibitor[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Episyringaresinol 4'-O-β-D-glncopyranoside inhibits NO production in LPS-induced N9 microglial cells dramatically in a dose independent manner with an IC50 of 91.50 μM. |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 778.5±60.0 °C at 760 mmHg |
| Molecular Formula | C28H36O13 |
| Molecular Weight | 580.578 |
| Flash Point | 424.6±32.9 °C |
| Exact Mass | 580.215576 |
| LogP | -1.60 |
| Vapour Pressure | 0.0±2.8 mmHg at 25°C |
| Index of Refraction | 1.601 |
| Storage condition | -20℃ |